ACTIVE

BIOTECH ENGINEERING

Financial year 2025 · Closed on 31/03/2025

Net result242,7 k €+22 835,2 %over 1 year

Gross margin419,1 k €+267,1 %over 1 year

Equity418,7 k €+93,8 %over 1 year

Identity

Source · BCE/KBO

BIOTECH ENGINEERING is a Private limited company incorporated in 1997. Its main activity is: Engineering activities and related technical consultancy. Its registered office is in Gent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0460.320.725
Incorporation: 28/03/1997
Legal form: Private limited company
Registered office: Amelia Earhartlaan 2 box 304
9051 Gent · FlandreSee on map
Contributed capital: 49 605,32 €
Latest accounts: 31/03/2025

Activities (NACE)

71121Engineering activities and related technical consultancy· main 71121Engineering activities and related technical consultancy

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	419,1 k €	+267%	114,1 k €	+3.4%	110,4 k €	-2.5%	113,2 k €	-18.3%	138,6 k €
EBITDA	335,2 k €	+922%	32,8 k €	-10.2%	36,5 k €	-13.0%	42 k €	-35.7%	65,3 k €
Operating result	317,2 k €	+4005%	7,7 k €	-28.1%	10,8 k €	-35.7%	16,7 k €	-61.7%	43,7 k €
Net result	242,7 k €	+22835%	1,1 k €	+271%	285,1 €	-99.0%	28,2 k €	-8.2%	30,7 k €
Balance sheet
Equity	418,7 k €	+93.8%	216 k €	+0.5%	215 k €	-61.9%	564,7 k €	+3.3%	546,5 k €
Total assets	787,6 k €	+42.8%	551,4 k €	+15.6%	477 k €	-41.3%	813 k €	+2.7%	791,5 k €
Cash	516,3 k €	+40.9%	366,5 k €	+3.6%	353,7 k €	-34.5%	540,3 k €	+3459%	15,2 k €
Debts	364,4 k €	+10.1%	331 k €	+28.2%	258,3 k €	+5.4%	245,1 k €	+1.7%	241,1 k €
Other
Workforce	–		–		–		1,0 ETP		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/03/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
BIOTECH-INVEST0476.881.001Represented by Katleen Lammens	Directorsince 01/10/2018Manager2012 accountsended
STEFAAN HEYVAERTS	DirectorManager2019 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Kathleen Lammens	Manager2019 accounts
KATHLEEN LAMMMENS	Manager2016 accounts
Katleen Lammens	Manager2017 accounts

Other companies at this address

Amelia Earhartlaan 2 9051 Gent

Company	CBE no.
100● Active	0743.478.472
101● Active	0743.479.561
102● Active	0743.480.353
10 Upkot● Active	0423.791.614
85● Active	0819.492.820
93● Active	0711.912.197
94● Active	0724.877.238
97● Active	0737.858.214
98● Active	0737.863.657
99● Active	0743.475.207
Andreas BidCo● Active	1016.654.327
ARE P0108● Active	0793.510.676
ART UPKOT● Active	0891.055.460
BACKSTAGE²UPKOT● Active	0454.973.748
BAUDELO UPKOT● Active	0545.801.677
BRO Upkot● Active	0662.477.930
Buzz Upkot● Active	0729.978.151
Campus Upkot● Active	0680.956.727
Constelaris● Active	1019.186.027
DD ENGINEERING● Active	0445.527.928

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Micro model	Abridged model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/08/2025	28/10/2024	29/09/2023	03/11/2022	01/10/2021	03/11/2020
General meeting	04/08/2025	30/09/2024	02/09/2023	03/10/2022	04/09/2021	05/10/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/03/2025	04/08/2025	04/08/2025	French	PDF
Micro model	31/03/2024	30/09/2024	28/10/2024	French	PDF
Micro model	31/03/2023	02/09/2023	29/09/2023	French	PDF
Abridged model	31/03/2022	03/10/2022	03/11/2022	French	PDF
Micro model	31/03/2021	04/09/2021	01/10/2021	French	PDF
Abridged model	31/03/2020	05/10/2020	03/11/2020	French	PDF
Abridged model	31/03/2019	07/09/2019	31/10/2019	French	PDF
Abridged model	31/03/2018	21/09/2018	22/10/2018	French	PDF
Abridged model	31/03/2017	23/09/2017	12/10/2017	French	PDF
Abridged model	31/03/2016	03/09/2016	30/09/2016	French	PDF
Abridged model	31/03/2015	05/09/2015	28/09/2015	French	PDF
Abridged model	31/03/2014	06/09/2014	29/09/2014	French	PDF
Abridged model	31/03/2013	28/09/2013	25/10/2013	French	PDF
Abridged model	31/03/2012	06/10/2012	27/10/2012	French	PDF
Abridged model	31/03/2011	03/09/2011	30/09/2011	French	PDF
Abridged model	31/03/2010	04/09/2010	27/09/2010	French	PDF
Abridged model	31/03/2009	05/09/2009	02/10/2009	French	PDF
Abridged model	31/03/2008	06/09/2008	01/10/2008	French	PDF
Abridged model	31/03/2007	01/09/2007	27/09/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
BIOTECH-INVEST0476.881.001Represented by Katleen Lammens	Directorsince 01/10/2018Manager2012 accountsended
STEFAAN HEYVAERTS	DirectorManager2019 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Kathleen Lammens	Manager2019 accounts
KATHLEEN LAMMMENS	Manager2016 accounts
Katleen Lammens	Manager2017 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other07/04/2026
STATUTEN (VERTALING, COORDINATIE, OVERIGE
PDF
Mandates13/03/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Mandates12/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates22/01/2020
DEMISSIONS, NOMINATIONS
PDF
Registered office23/03/2007
Modification de siège social
PDF
Other14/12/2005
MODIFICATION DES STATUTS |
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

BIOTECH-INVEST

STEFAAN HEYVAERTS

KATHLEEN LAMMMENS

Katleen Lammens

Kathleen Lammens

199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

BIOTECH ENGINEERING

Rue de la Grande Couture 2, 7522 Blandain

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Amelia Earhartlaan 2 bte 304, 9051 Sint-Denijs-WestremCurrent		CBE
Rue de la Grande Couture 2, 7522 Blandain	accounts 2022 → 2025	Accounts 2025 · 2025-00360057

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
BIOTECH ENGINEERINGCurrent	accounts 2022 → 2025	Accounts 2025 · 2025-00360057

Events

2025
Annual accounts 2025242,7 k €↑
2024
Annual accounts 20241,1 k €↑
2023
Annual accounts 2023285,1 €↓
2022
Annual accounts 202228,2 k €↓
2021
Annual accounts 202130,7 k €↓
2020
Annual accounts 202048,7 k €↑
2019
Annual accounts 201931,5 k €↓
2018
Annual accounts 201845,8 k €↓
2017
Annual accounts 201784,5 k €↓
2016
Annual accounts 2016122,3 k €↓
2015
Annual accounts 2015164,4 k €↑
2014
Annual accounts 201488,9 k €↑
2013
Annual accounts 201310,5 k €↓
2012
Annual accounts 201255,2 k €↑
2011
Annual accounts 201120,7 k €↓
2010
Annual accounts 201035,7 k €↑
2009
Annual accounts 200929,7 k €↓
2008
Annual accounts 200838,3 k €↓
2007
Annual accounts 200760,4 k €
28/03/1997
IncorporationPrivate limited company

BIOTECH ENGINEERING

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events